Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.